Evidence map›Paper›PMID 31602249›Full record

ArticleExperimental and therapeutic medicine2019

Clinical relevance of a CD4

Wei Liu, Kai Wang, Yi-He Zhao, Guang-Ping Song, Wei Gao, Dai-Hong Li

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Association between CD4Oncology letters · 2024
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wei LiuDepartment of Blood Transfusion, Tianjin First Central Hospital, Tianjin 300192, P.R. China.
Kai WangDepartment of Transplantation Surgery, Tianjin First Central Hospital, Tianjin 300192, P.R. China.
Yi-He ZhaoDepartment of Blood Transfusion, Tianjin First Central Hospital, Tianjin 300192, P.R. China.
Guang-Ping SongDepartment of Blood Transfusion, Tianjin First Central Hospital, Tianjin 300192, P.R. China.
Wei GaoDepartment of Transplantation Surgery, Tianjin First Central Hospital, Tianjin 300192, P.R. China.
Dai-Hong LiDepartment of Blood Transfusion, Tianjin First Central Hospital, Tianjin 300192, P.R. China.
Tianjin First Center Hospital · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to investigate the potential of the Immuknow immune cell function assay for the diagnosis of infection after pediatric living-donor liver transplantation (LDLT). Based on clinical data obtained following liver transplantation, 66 patients were divided into infection (n=28) and non-infection (n=38) groups. The following factors were considered in the present analysis: Primary disease, lymphocyte count, tacrolimus plasma concentration/dose (C

Indexed as

Immuknowinfectionpediatric living-donor liver transplantation

Identifiers

PMID31602249
PMCPMC6777337
OpenAlexW2972923298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.